| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 18 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $18.58M | - | |
| CFO | 826.6K | $5.60M | - | |
| Dir | 225.0K | $1.52M | - | |
| Dir | 215.5K | $1.46M | - | |
| Dir | 174.3K | $1.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Raykov Rosty55 | Chief Executive Officer | Sell | 25,044 | $7.76 | $194,267.31 | -4.2% | +32.3% | -42.8% | |
| Aug 18, 2023 | Rallis Chris A62 | Director | Sell | 673 | $7.85 | $5,283.05 | -1.5% | +3.2% | -29.0% | |
| Jul 24, 2023 | Rallis Chris A62 | Director | Sale+OE | 6,796 | $8.17 | $55,523.32 | -13.4% | -16.3% | -17.5% | |
| Jul 6, 2023 | Rallis Chris A62 | Director | Sale+OE | 2,207 | $8.47 | $18,693.29 | -7.1% | -24.4% | -32.3% | |
| Jun 30, 2023 | Andrade Robert69 | Chief Financial Officer | Sale+OE | 25,000 | $8.93 | $223,325.00 | -5.9% | -19.0% | -30.8% | |
| May 19, 2023 | Rallis Chris A62 | Director | Sell | 1,758 | $7.36 | $12,938.88 | -2.7% | +5.8% | -5.8% | |
| Dec 30, 2022 | Raykov Rosty55 | Chief Executive Officer | Sell | 28,740 | $9.61 | $276,223.76 | -3.1% | -10.9% | +16.9% | |
| Dec 30, 2022 | Andrade Robert69 | Chief Financial Officer | Sell | 22,000 | $9.60 | $211,288.00 | -4.5% | -10.9% | +16.9% | |
| Nov 17, 2022 | Rallis Chris A62 | Director | Sell | 333 | $7.99 | $2,660.67 | -1.1% | +15.5% | +1.6% | |
| May 4, 2020 | Southpoint Capital Advisors LP62 | 10% Owner | Buy | 80,000 | $6.25 | $500,000.00 | +2.0% | - | - |